The pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.
In-Sun Oh, BA
Advertisement
Articles by In-Sun Oh, BA
Advertisement
Latest Updated Articles
- Prescribing Trend of Pioglitazone After Safety Warning Release in Korea
Published: November 19th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
How Medicaid Reforms Could Deepen State Coverage Gaps
3
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
4
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
5
